Pivekimab is a human IgG1 monoclonal antibody targeting interleukin 3 (IL-3) and CD123. Pivekimab can be used in the study of blastocytic plasmacytoid dendritic cell tumor (BPDCN).
CAS Number:
[2234335-84-1]
Target:
IL Receptor/Related
* VAT and and shipping costs not included. Errors and price changes excepted
